Edit

Amferia AB

https://amferia.com/

Last activity: 30.07.2026

Active

Categories: AntimicrobialBiotechHydrogelMedTechWoundCare

Amferia develops innovative medical devices to provide solutions to the global antibiotic resistance crisis. Amferia’s goal is to provide highly efficient anti-infective medical devices that can prevent infections.

Likes

Mentions

Location: Sweden

Employees: 11-50

Total raised: $5.42M

Founded date: 2018

Facebook

Investors 3

Date	Name	Website
-	BioVenture...	azbioventu...
-	Almi Inves...	almi.se
-	Chalmers V...	chalmersve...

Funding Rounds 2

Date	Series	Amount	Investors
12.02.2026	-	$4.09M	-
03.09.2024	-	$1.33M	-

Mentions in press and media 24

Date	Title	Description
30.07.2026	Amferia Strengthens Advanced Wound Care Platform with ISO 13485 Quality Certification	Amferia Strengthens Advanced Wound Care Platform with ISO 13485 Quality Certification Thu, Jul 30, 2026 10:28 CET Report this content The certification reflects Amferia’s commitment to quality throughout the product lifecycle and complement...
29.06.2026	Amferia Reaches Milestone of 33 Granted Patents Across 20 Jurisdictions, Positioning the Company for Growth in the Antimicrobial Wound Care Market	Amferia Reaches Milestone of 33 Granted Patents Across 20 Jurisdictions, Positioning the Company for Growth in the Antimicrobial Wound Care Market Mon, Jun 29, 2026 11:30 CET Report this content From a single novel hydrogel patent filed in ...
16.06.2026	Amferia Annual General Meeting (AGM) Appoints Global Healthcare Leaders Randy Schwartz and Nikolaj Sørensen to Board of Directors	Amferia Annual General Meeting (AGM) Appoints Global Healthcare Leaders Randy Schwartz and Nikolaj Sørensen to Board of Directors Tue, Jun 16, 2026 10:18 CET Report this content Amferia AB is pleased to announce the appointment of two new b...
29.04.2026	Following the U.S. FDA De Novo Classification, Amferia Seeks Potential Partners to Market the World’s First Antibacterial Peptide-Based Wound Dressing	Following the U.S. FDA De Novo Classification, Amferia Seeks Potential Partners to Market the World’s First Antibacterial Peptide-Based Wound Dressing Wed, Apr 29, 2026 12:04 CET Report this content With the FDA De Novo Classification grant...
16.04.2026	Amferia Signs Major Animal Health Distribution Contract with Interchem (Ireland) Ltd, Expanding into Ireland	Amferia Signs Major Animal Health Distribution Contract with Interchem (Ireland) Ltd, Expanding into Ireland Thu, Apr 16, 2026 08:00 CET Report this content Amferia, a Swedish medtech company developing next-generation peptide-based wound c...
16.02.2026	Amferia's Breakthrough Antimicrobial Hydrogel Wins Landmark FDA Approval, Bolstering Fight Against AMR	Amferia, a Swedish medtech innovator, recently secured €3.5 million to advance its groundbreaking antimicrobial peptide (AMP) hydrogel technology. The company also achieved a significant milestone: U.S. FDA De Novo classification. This appr...
12.02.2026	FDA Grants De Novo Classification Request to Market the World’s First Antibacterial Peptide-Based Wound Dressing	FDA Grants De Novo Classification Request to Market the World’s First Antibacterial Peptide-Based Wound Dressing Thu, Feb 12, 2026 11:22 CET Report this content In granting the De Novo Classification Request, FDA allows Swedish medtech firm...
05.02.2026	Amferia signs major contract in Animal Health with Grovet BV and Expands into the Benelux markets	Amferia signs major contract in Animal Health with Grovet BV and Expands into the Benelux markets Thu, Feb 05, 2026 08:00 CET Report this content Mölndal, Sweden — February 5, 2026 — An innovative new wound care technology will now allow ve...
27.01.2026	Medtech Firm Amferia signs major contract in Animal Health with Magnum Veterinaaria and Expands into the Baltic States	Medtech Firm Amferia signs major contract in Animal Health with Magnum Veterinaaria and Expands into the Baltic States Tue, Jan 27, 2026 08:00 CET Report this content Mölndal, Sweden — January 27, 2026 — An innovative new wound care technol...
15.12.2025	Medtech Firm Amferia Secures €3.5M Investment to Accelerate Breakthrough Antimicrobial Technology in Human and Animal Health	Medtech Firm Amferia Secures €3.5M Investment to Accelerate Breakthrough Antimicrobial Technology in Human and Animal Health Mon, Dec 15, 2025 08:00 CET Report this content Mölndal, Sweden — December 15, 2025 — Amferia, a Swedish medtech co...
19.11.2025	Amferia Technology: Breakthrough Antimicrobial Solution for Animal Wound Care	Amferia Technology: Breakthrough Antimicrobial Solution for Animal Wound Care Wed, Nov 19, 2025 10:57 CET Report this content Amferia has invented a new antimicrobial hydrogel wound dressing using a peptide technology, that targets, binds, ...
23.10.2025	Therese Rydell Joins Amferia as Director of Quality and Regulatory Affairs	Therese Rydell Joins Amferia as Director of Quality and Regulatory Affairs Thu, Oct 23, 2025 08:34 CET Report this content Amferia AB is happy to welcome Therese Rydell as the Director of Quality and Regulatory Affairs. Therese has extensiv...
19.11.2024	A New Dawn in Antibiotic Efficacy: Peptide-Hydrogel Combats Resistance	In the battle against antibiotic resistance, a new weapon has emerged from the labs of Chalmers University of Technology in Sweden. Researchers have developed a peptide-hydrogel that dramatically enhances the effectiveness of antibiotics ag...
18.11.2024	Antibacterial material restores the efficacy of antibiotics against resistant bacteria	Antibacterial material restores the efficacy of antibiotics against resistant bacteria Mon, Nov 18, 2024 07:00 CET Report this content WHO World Antimicrobial Resistance Awareness Week starts today: Research from Chalmers University of Tech...
18.11.2024	New Study finds innovative Peptide-Hydrogel restores the effectiveness of antibiotics against drug-resistant bacteria	New Study finds innovative Peptide-Hydrogel restores the effectiveness of antibiotics against drug-resistant bacteria Mon, Nov 18, 2024 09:04 CET Report this content Swedish med-tech firm Amferia announced findings that antibiotic-resistant...
14.11.2024	Amferia Recognized on Ny Teknik’s Prestigious “33-listan” for Second Consecutive Year	Amferia Recognized on Ny Teknik’s Prestigious “33-listan” for Second Consecutive Year Thu, Nov 14, 2024 17:12 CET Report this content The significance of being on the list a second time highlights Amferia's continued growth and increasing m...
11.11.2024	Amferia and Chalmers University: Pioneering Innovations in Health and Technology	In a world where bacterial infections loom larger than ever, Swedish medtech company Amferia is stepping up to the plate. Recently, they snagged the prestigious Red Dot Award for their innovative design aimed at combating antibiotic resista...
11.11.2024	Amferia wins Red Dot Award for Innovative Design addressing bacterial infections and antibiotic resistance	Amferia wins Red Dot Award for Innovative Design addressing bacterial infections and antibiotic resistance Mon, Nov 11, 2024 10:00 CET Report this content Swedish medtech company Amferia has been awarded the Red Dot Award for its elevator p...
30.10.2024	First Product Utilizing Amferia Antimicrobial Technology Launched in Europe for Animal Wound Care	First Product Utilizing Amferia Antimicrobial Technology Launched in Europe for Animal Wound Care Wed, Oct 30, 2024 08:00 CET Report this content The Snögg BactiDefend Dressing, a new product in animal wound care using Amferia’s proprietary...
03.09.2024	Amferia closes €1,2 million investment to combat resistant bacterial infections	Amferia closes €1,2 million investment to combat resistant bacterial infections Tue, Sep 03, 2024 07:00 CET Report this content Swedish medtech company Amferia announces the successful completion of its latest investment round, boosting its...
03.09.2024	Swedish medtech Amferia snaps €1.2 million to combat resistant bacterial infections	Mölndal-based Amferia, a Swedish medtech company focused on developing innovative antimicrobial healthcare solutions, closed a €1,2 million investment round spearheaded by existing owners and a few new investors, including Chalmers Ventures...
26.08.2024	Amferia signs major animal health contract with Biokema and expands into Switzerland	Amferia signs major animal health contract with Biokema and expands into Switzerland Mon, Aug 26, 2024 11:56 CET Report this content Swedish medtech company Amferia, with a mission to combat infections globally, announces the signing of its...
-	Amferia	“Amferia \| Amferia kills bacteria”
-	Amferia	“Amferia kills bacteria”

Amferia AB

Investors 3

Funding Rounds 2

Mentions in press and media 24

Reviews 0